ProCE Banner Activity

Advances in Metastatic Breast Cancer Care: Guidance on Antibody–Drug Conjugate Therapy for the Community Multidisciplinary Team

Slideset

Download this regularly updated slideset for expert insights on incorporating antibody–drug conjugates into community care of metastatic breast cancer, including patient selection, deciding among agents, and managing toxicities.

Released: March 22, 2023

Share

Faculty

Sara A. Hurvitz

Sara A. Hurvitz, MD, FACP

Professor of Medicine
Head, Division of Hematology and Oncology
Department of Medicine, UW Medicine
Senior Vice President
Clinical Research Division
Fred Hutchinson Cancer Center
Seattle, Washington

Sara M. Tolaney

Sara M. Tolaney, MD, MPH

Assistant Professor of Medicine
Harvard Medical School
Associate Director
Susan F. Smith Center for Women’s Cancers
Director
Clinical Trials, Breast Oncology
Director
Breast Immunotherapy Clinical Research
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca; Daiichi Sankyo, Inc.; and Gilead Sciences, Inc.

AstraZeneca

Daiichi Sankyo, Inc.

Gilead Sciences, Inc.